MFA
EW icon

Mayflower Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Mayflower Financial Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
5,029
-440
-8% -$36.9K 0.04% 301
2026
Q1 		$438K Buy
5,469
+202
+4% +$16.7K 0.05% 284
2025
Q4 		$449K Sell
5,267
-295
-5% -$24.2K 0.05% 267
2025
Q3 		$433K Buy
5,562
+20
+0.4% +$1.56K 0.05% 274
2025
Q2 		$433K Buy
5,542
+1
+0% +$75 0.06% 259
2025
Q1 		$402K Sell
5,541
-34
-0.6% -$2.43K 0.06% 259
2024
Q4 		$413K Buy
5,575
+68
+1% +$4.76K 0.06% 251
2024
Q3 		$363K Sell
5,507
-20
-0.4% -$1.45K 0.05% 265
2024
Q2 		$511K Sell
5,527
-31
-0.6% -$2.75K 0.08% 207
2024
Q1 		$531K Buy
+5,558
New +$467K 0.09% 202
2023
Q3 		– Sell
-2,471
Closed -$233K – 346
2023
Q2 		$233K Buy
2,471
+20
+0.8% +$1.74K 0.03% 314
2023
Q1 		$203K Buy
+2,451
New +$193K 0.03% 331
2022
Q3 		– Sell
-2,487
Closed -$236K – 345
2022
Q2 		$236K Buy
2,487
+12
+0.5% +$1.24K 0.04% 290
2022
Q1 		$291K Buy
2,475
+326
+15% +$36.6K 0.04% 274
2021
Q4 		$278K Buy
2,149
+4
+0.2% +$467 0.04% 279
2021
Q3 		$247K Sell
2,145
-31
-1% -$3.54K 0.03% 288
2021
Q2 		$225K Buy
+2,176
New +$205K 0.03% 285

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mayflower Financial Advisors's EW Position: Q2 2026 in Review

Mayflower Financial Advisors reduced its Edwards Lifesciences (EW) stake by 8% in Q2 2026, selling an estimated $36.9K and leaving 5,029 shares worth $455K. The position accounts for 0.04% of the portfolio, ranked #301.

Mayflower Financial Advisors first reported a position in EW in Q2 2021 and has held it in 17 quarters since. The position peaked at $531K in Q1 2024. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mayflower Financial Advisors held 5,029 shares of Edwards Lifesciences worth $455K as of Q2 2026.
  • Mayflower Financial Advisors sold 440 Edwards Lifesciences shares in Q2 2026, an estimated $36.9K.
  • Edwards Lifesciences made up 0.04% of Mayflower Financial Advisors's portfolio in Q2 2026, its #301 holding.
  • Mayflower Financial Advisors first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 17 quarters since.
  • Mayflower Financial Advisors's Edwards Lifesciences position peaked at $531K in Q1 2024.
  • 458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.